comparemela.com

Frank Tufaro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Theriva Biologics (TOVX) Q3 2022 Earnings Call Transcript

Theriva Biologics (NYSE:NYSE:TOVX) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Chris Calabrese - Investor Relations Steven Shallcross - Chief Executive.

Frank tufaroVince wacherTheriva biologics europeChris calabreseTheriva biologicsManel cascallSteven shallcrossJim molloyExchange commissionCompany participantsProduct developmentAlliance global partnersProduct development of theriva biologicsConference call novemberChief financialSynthetic biologics

Synthetic Biologics Reports First Quarter 2022 Operational

-Encouraging data further supports the development of novel oncolytic adenovirus (OV) platform; Announced a peer-reviewed publication highlighting positive.

United statesIsrael generalFrank tufaroStevena shallcrossDaniel dimaioInvestigacio biomedicaRamon alemanyManel cascallMarks blumenkranzJosep taberneroEnnio antonio chioccaTom dubenskyDepartment of ophthalmology at stanford universityHebron university hospitalYale cancer centerTherapeutic radiology at yale school of medicine

Synthetic Biologics, Inc (SYN) CEO Steven Shallcross on Q1 2022 Results - Earnings Call Transcript

Synthetic Biologics, Inc. (NYSE:NYSE:SYN) Q1 2022 Earnings Conference Call May 16, 2022, 09:00 AM ET Company Participants Dean Schwartz - LifeSci Advisors, IR Steven Shallcross - CEO and.

United statesSouth koreaJason mccarthyFrank tufaroVince wacherLeland gershellManel cascalloJo anne leeSteven shallcrossManuel hidalgoJim molloyCompany participantsProduct development of synthetic biologicsAlliance global partnersUniversity at leedsMeeting of the american society gene

Synthetic Biologics Announces Management Transitions in

-Frank Tufaro, Ph.D., appointed as Chief Operating Officer of Synthetic Biologics, transitioning from Chief Operating Officer of VCN Biosciences- -Manel.

United statesFrank tufaroManel cascallStevena shallcrossNeurovir incNurel therapeutics incDnatrix incEmergex united states corporationSynthetic biologics incProtocol intelligence incChief operating officerSynthetic biologicsGeneral directorSynthetic biologic european subsidiarySynthetic biologicChief executive officer

vimarsana © 2020. All Rights Reserved.